Meridian Bioscience reported $471.81M in Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Abbott ABT:US $ 74007M 1189M
Accelerate Diagnostics AXDX:US 70.36M 12.69M
Atrion ATRI:US 267.26M 1.67M
Becton, Dickinson and BDX:US $ 54786M 1423M
Bio Rad Laboratories BIO:US $ 14373.7M 3402.1M
Cerulean Pharma CERU:US $ 49.19M 6.62M
Cerus CERS:US $ 221.91M 15.59M
Meridian Bioscience VIVO:US $ 471.81M 13.17M
Myriad Genetics MYGN:US $ 1255.4M 65.3M
Orasure Technologies OSUR:US $ 435.53M 25.46M
Quidel QDEL:US $ 3093.12M 662.75M
Sientra SIEN:US $ 191.87M 8.04M
Staar Surgical STAA:US $ 351.18M 5.4M
Thermo Fisher Scientific TMO:US $ 92747M 2376M
Trinity Biotech TRIB:US $ 106.1M 12.8M
Utah Medical Products UTMD:US $ 119.75M 5.36M